TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein

Molecular and Cellular Neuroscience

Volumn 35, Issue 2, 2007, Pages 320-327

  Strong, Michael J ^a,b   Volkening, Kathryn ^a   Hammond, Robert ^b   Yang, Wencheng ^a   Strong, Wendy ^a   Leystra Lantz, Cheryl ^a   Shoesmith, Christen ^b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Amyotrophic lateral sclerosis; mRNA stability; Neurofilament; Translational regulation

Indexed keywords

DNA BINDING PROTEIN; MESSENGER RNA; NEUROFILAMENT PROTEIN; PROTEIN TDP 43; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOSOL; EMBRYO; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MOTONEURON; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

3' UNTRANSLATED REGIONS; ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; BASE SEQUENCE; BRAIN; CELL LINE, TRANSFORMED; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; HUMANS; IMMUNOPRECIPITATION; MALE; MIDDLE AGED; MOLECULAR WEIGHT; MOTOR NEURONS; NEUROFILAMENT PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RNA, MESSENGER; SPINAL CORD; TRANSFECTION; UBIQUITIN;

EID: 34249751076     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2007.03.007     Document Type: Article

References (46)

1. Anderson P., and Kedersha N. RNA granules. J. Cell Biol. 172 (2006) 803-808
2. Antic D., Lu N., and Keene J.D. ELAV tumor antigen, Hel-N1, increases translation of neurofilament M mRNA and induces formation of neurites in human teratocarcinoma cells. Genes Dev. 13 (1999) 449-461
3. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., and Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 51 (2006) 602-611
4. Ayala Y.M., Pagani F., and Baralle F.E. TDP-43 depletion rescues aberrant CFTR exon 9 skipping. FEBS Lett. 580 (2006) 1339-1344
5. Bergeron C., Beric-Maskarel K., Muntasser S., Weyer L., Somerville M., and Percy M.E. Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons. J. Neuropathol. Exp. Neurol. 53 (1994) 221-230
6. Buratti E., and Baralle F.E. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J. Biol. Chem. 276 (2001) 36337-36343
7. Buratti E., Dörk T., Zuccato E., Pagani F., Romano M., and Baralle F.E. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO 20 (2001) 1774-1784
8. Buratti E., Brindisi A., Pagani F., and Baralle F.E. Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR Intron 8 and causes skipping of exon 9: a functional link with disease penetrance. Am. J. Hum. Genet. 74 (2004) 1322-1325
9. Cañete-Soler R., Schwartz M.L., Hua Y., and Schlaepfer W.W. Stability determinants are localized to the 3′-untranslated region and 3′-coding region of the neurofilament light subunit mRNA using a tetracycline-inducible promoter. J. Biol. Chem. 273 (1998) 12650-12654
10. Cañete-Soler R., Schwartz M.L., Hua Y., and Schlaepfer W.W. Characterization of ribonucleoprotein complexes and their binding sites on the neurofilament light subunit mRNA. J. Biol. Chem. 273 (1998) 12655-12661
11. Cañete-Soler R., Silberg D.G., Gershon M.D., and Schlaepfer W.W. Mutation in neurofilament transgene implicates RNA processing in the pathogenesis of neurodegenerative disease. J. Neurosci. 19 (1999) 1272-1283
12. Cañete-Soler R., Wu J., Zhai J., Shamim M., and Schlaepfer W.W. p190RhoGEF binds to a destabilizing element in the 3′ untranslated region of light neurofilament subunit mRNA and alters the stability of the transcript. J. Biol. Chem. (2001) 276-32046
13. Cañete-Soler R., Reddy K.S., Tolan D.R., and Zhai J. Aldolases A and C are ribonucleolytic components of a neuronal complex that regulates the stability of the light-neurofilament mRNA. J. Neurosci. 25 (2005) 4353-4364
14. Chabanon H., Mickleburgh I., and Hesketh J. Zipcodes and postage stamps: mRNA localisation signals and their trans-acting binding proteins. Brief. Funct. Genomics and Proteomics 3 (2006) 240-256
15. Ching G.Y., and Liem R.K.H. Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments. J. Cell Biol. 122 (1993) 1323-1335
16. Elvira G., Wasiak S., Blandford V., Tong X.-K., Serrano A., Fan X., del Rayo Sánchez-Carbente M., Servant F., Bell A.W., Boismenu D., Lacaille J.-C., McPherson P.S., DesGroseillers L., and Sossing W.S. Characterization of an RNA granule from developing brain. Mol. Cell. Proteomics 5 (2006) 635-651
17. Ge W., Wu J., Zhai J., Nie Z., Lin H., Schlaepfer W.W., and Cañete-Soler R. Binding of p190RhoGEF to a destabilizing element on the light neurofilament mRNA is competed by BC1 RNA. J. Biol. Chem. 277 (2002) 42705-42710
18. Ge W., Leystra-Lantz C., Wen W., and Strong M.J. Selective loss of trans-acting instability determinants of neurofilament mRNA in amyotrophic lateral sclerosis spinal cord. J. Biol. Chem. 278 (2003) 26558-26563
19. Ge W.W., Wen W., Strong W.L., Leystra-Lantz C., and Strong M.J. Mutant copper/zinc superoxide dismutase binds to and destabilizes human low molecular weight neurofilament mRNA. J. Biol. Chem. 280 (2005) 118-124
20. Ge W.W., Leystra-Lantz C., Sanelli T.R., McLean J., Wen W., Strong W.L., and Strong M.J. Neuronal tissue-specific ribonucleoprotein complex formation on SOD1 mRNA: alterations by ALS SOD1 mutations. Neurobiol. Dis. 23 (2006) 342-350
21. Ge W., Volkening K., Leystra-Lantz C., Jaffe H., and Strong M.J. 14-3-3 Protein binds to the low molecular weight neurofilament (NFL) mRNA 3′ UTR. Mol. Cell. Neurosci. 34 (2007) 80-87
22. Gringhuis S.I., García-Vallejo J.J., van het Hof B., and van Dijk W. Convergent actions of IκB kinase β and protein kinase Cδ modulate mRNA stability through phosphorylation of 14-3-3β complexed with tristetraprolin. Mol. Cell. Biol. 25 (2005) 6454-6463
23. Kawamoto Y., Akiguchi I., Nakamura A., and Budka H. 14-3-3 Proteins in Lewy body-like hyaline inclusion in patients with sporadic amyotrophic lateral sclerosis. Acta Neuropathol. 108 (2004) 531-537
24. Kiebler M.A., and Bassell G.J. Neuronal RNA granules: movers and makers. Neuron 51 (2006) 685-690
25. Krichevsky A.M., and Kosik K.S. Neuronal RNA granules: a link between RNA localization and stimulation-dependent translation. Neuron 32 (2001) 683-696
26. Larivière R.C., and Julien J.-P. Functions of intermediate filaments in neuronal development and disease. J. Neurobiol. 58 (2004) 131-148
27. Lee M.K., Xu Z., Wong P.C., and Cleveland D.W. Neurofilaments are obligate heteropolymers in vivo. J. Cell Biol. 122 (1993) 1337-1350
28. Li Y., Jiang Z., Chen H., and Ma W.-J. A modified quantitative EMSA and its application in the study of RNA-protein interactions. J. Biochem. Biophys. Methods 60 (2004) 85-96
29. Lin H., Zhai J., and Schlaepfer W.W. RNA-binding protein is involved in aggregation of light neurofilament protein and is implicated in the pathogenesis of motor neuron degeneration. Hum. Mol. Genet. 14 (2005) 3643-3659
30. Ma A.S., Moran-Jones K., Shan J., Munro T.P., Snee M.J., Hoek K.S., and Smith R. Heterogeneous nuclear ribonucleoprotein A3, a novel RNA trafficking response element-binding protein. J. Biol. Chem. 277 (2002) 18010-18020
31. Makeyev A.V., and Liebhaber S.A. The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms. RNA 8 (2002) 265-278
32. Malaspina A., Kaushik N., and de Belleroche J. A 14-3-3 mRNA is up-regulated in amyotrophic lateral sclerosis spinal cord. J. Neurochem. 75 (2000) 2511-2520
33. Menzies F.M., Grierson A.J., Cookson M.R., Heath P.R., Tomkins J., Figlewicz D.A., Ince P.G., and Shaw P.J. Selective loss of neurofilament expression in Cu/Zn superoxide dismutase (SOD1) linked amyotrophic lateral sclerosis. J. Neurochem. 82 (2002) 1118-1128
34. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., and Lee V.M.Y. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 (2006) 130-133
35. Nie Z., Wu J., Zhai J., Lin H., Ge W., Schlaepfer W.W., and Cañete-Soler R. Untranslated element in neurofilament mRNA has neuropathic effect on motor neurons of transgenic mice. J. Neurosci. 22 (2002) 7662-7670
36. Nixon R.A., and Shea T.B. Dynamics of neuronal intermediate filaments: a developmental perspective. Cell Motil. Cytoskel. 22 (1992) 81-91
37. Ou S.-H.I., Wu F., Harrich D., García-Martínez L.F., and Gaynor R.B. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol. 69 (1995) 3584-3596
38. Shan J., Moran-Jones K., Munro T.P., Kidd G.K., Winzor D.J., Hoek K., and Smith R. Binding of an RNA trafficking response element to heterogeneous nuclear ribonucleoproteins A1 and A2. J. Biol. Chem. 275 (2000) 38286-38295
39. Shyu A.B., and Wilkinson M.F. The double lives of shuttling mRNA binding proteins. Cell 102 (2000) 135-138
40. Snee M., Kidd G.J., Munro T.P., and Smith R. RNA trafficking and stabilization elements associate with multiple brain proteins. J. Cell Sci. 115 (2002) 4661-4669
41. Strong M.J., Leystra-Lantz C., and Ge W. Intermediate filament steady state mRNA levels in amyotrophic lateral sclerosis (ALS). Biochem. Biophys. Res. Commun. 316 (2004) 317-322
42. Strong M.J., Kesavapany S., and Pant H.C. The pathobiology of amyotrophic lateral sclerosis: a proteinopathy?. J. Neuropathol. Exp. Neurol. 64 (2005) 649-664
43. Thyagarajan A., and Szaro B.G. Phylogenetically conserved binding of specific K homology domain proteins to the 3′-untranslated region of the vertebrate middle neurofilament mRNA. J. Biol. Chem. 279 (2004) 49680-49868
44. Wilhelm J.E., and Vale R.D. RNA on the move: the mRNA localization pathway. J. Cell Biol. 123 (1993) 269-274
45. Wong N., He B.P., and Strong M.J. Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS). J. Neuropathol. Exp. Neurol. 59 (2000) 972-982
46. Zalfa F., Achsel T., and Bagni C. mRNPs, polysomes or granules: FRMP in neuronal protein synthesis. Curr. Opin. Neurobiol. 16 (2006) 265-269